Tourette syndrome

(redirected from Tourette's Disorder)
Also found in: Medical.

Tou·rette syndrome

 (to͝o-rĕt′) or Tou·rette's syndrome (-rĕts′)
n.
A neurological disorder characterized by multiple motor and vocal tics, such as blinking, shrugging, sniffing, or repeating phrases. It is usually diagnosed in childhood or adolescence and often becomes less severe in adulthood. Also called Gilles de la Tourette syndrome.

[After Georges Gilles de la Tourette (1857-1904), French physician.]

Tourette syndrome

(tʊəˈrɛt)
n
(Pathology) a brain disorder characterized by involuntary outbursts of swearing, spitting, barking, etc, and sudden involuntary movements. Also called: Gilles de la Tourette syndrome, Tourette's syndrome or Tourette's
[C20: named after Georges Gilles de la Tourette (1857–1904), French neurologist]
Translations

Tourette syndrome

[tʊəˈrɛtˌsɪndrəʊm] Tourette's syndrome [tʊəˈrɛtsˌsɪndrəʊm] Nsíndrome m de Tourette

Tourette(’s) syndrome

nTourettesyndrom nt
References in periodicals archive ?
Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder.
There is no other family history of neurodevelopmental disorders, including no obsessive compulsive disorder (OCD), Tourette's disorder, or other chronic tic disorders.
Specifically, this study examined GABA levels in both the POC (Parietal-Occipital Cortex) a grey matter rich region thought to be associated with epilepsy, and which was previously studied for vigabatrin, and the SMA (Supplementary Motor Area), which is thought to be associated with Tourette's Disorder.
M2 PHARMA-October 14, 2015-Catalyst announces USPTO's notice of allowance for the method of treating Tourette's Disorder with GABA-aminotransferase inactivators
M2 EQUITYBITES-October 14, 2015-Catalyst announces USPTO's notice of allowance for the method of treating Tourette's Disorder with GABA-aminotransferase inactivators
Their topics include weighing the benefits and challenges of available treatments for disruptive disorders, the epidemiology and course of disruptive disorders, attention-deficit/hyperactivity disorder, Tourette's disorder and other tic disorders, intellectual disability and autism spectrum disorder, and neurocognitive disorders and delirium.
A controlled family study of attention-deficit/hyperactivity disorder and Tourette's disorder.
Neurobiological substrates for Tourette's disorder.
Young, included: Decreasing Anxiety and Improving Written Output with Learning Disabilities and A New Hypnobehavioral Method for Treatment of Children with Tourette's Disorder.